ZIF-8 nano confined protein-titanocene complex core-shell MOFs for efficient therapy of Neuroblastoma: Optimization, molecular dynamics and toxicity studies

Int J Biol Macromol. 2021 May 1:178:444-463. doi: 10.1016/j.ijbiomac.2021.02.161. Epub 2021 Feb 24.

Abstract

In the present study, we have developed the core-shell metal organic framework (MOF) of zinc, wherein titanocene dichloride (TC) loaded lactoferrin (Lf) functioned as a core. The complexation of TC to Lf was studies using molecular dynamics study, Quantum mechanical model and spectroscopic investigations. Plackett-Burman design was used to screen and select the critical factors affecting the responses (size, zeta potential and PDI) while the effect of those parameter on the quality attributes (size and yield) was studied by means of a Box-Behnken design. The optimised Lf-TC nanoparticles were loaded inside the ZIF-8 framework along with an anticancer agent 5 Fluorouracil and characterized using techniques like FTIR, PXRD, Raman spectroscopy, EDX and UV-NIR spectroscopy and morphological techniques like SEM, TEM, AFM. The compatibility of the loaded ZIF-8 framework was examined by haemocompatibility studies. The potential of developed nanoplatform against Neuroblastoma was assessed using a cell line studies along with in vivo toxicity studies to ascertain its safety for after in-vivo administration in Wistar rats. Therefore, we can conclude that by employing the approach of DOE we were able to optimize the size and yield of Lf-TC NPs and further by loading inside ZIF-8 framework along with an anticancer drug like 5 fluorouracil we were able to develop a potential nanoplatform for the multimodal therapy of Neuroblastoma.

Keywords: Box-Behnken design; Lactoferrin; Molecular dynamics; Titanocene dichloride; Toxicity; ZIF-8.

MeSH terms

  • Animals
  • Antineoplastic Agents* / adverse effects
  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / pharmacology
  • Fluorouracil* / adverse effects
  • Fluorouracil* / chemistry
  • Fluorouracil* / pharmacology
  • Imidazoles* / adverse effects
  • Imidazoles* / chemistry
  • Imidazoles* / pharmacology
  • Metal-Organic Frameworks* / adverse effects
  • Metal-Organic Frameworks* / chemistry
  • Metal-Organic Frameworks* / pharmacology
  • Molecular Dynamics Simulation*
  • Nanoparticles* / adverse effects
  • Nanoparticles* / chemistry
  • Nanoparticles* / therapeutic use
  • Neuroblastoma* / drug therapy
  • Neuroblastoma* / metabolism
  • Organometallic Compounds* / adverse effects
  • Organometallic Compounds* / chemistry
  • Organometallic Compounds* / pharmacology
  • Rats
  • Rats, Wistar

Substances

  • Antineoplastic Agents
  • Imidazoles
  • Metal-Organic Frameworks
  • Organometallic Compounds
  • ZIF-8 metal-organic framework
  • titanocene
  • Fluorouracil